+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human breast cancer tissue using P08824(ARMC10 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human lung cancer tissue using P08824(ARMC10 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

The ARMC10 (Armadillo Repeat Containing 10) protein is a relatively understudied member of the Armadillo (ARM) repeat-containing protein family, characterized by tandem repeats of ~40 amino acid motifs that mediate protein-protein interactions. ARMC10 is evolutionarily conserved and ubiquitously expressed across tissues, with emerging roles in mitochondrial dynamics, cellular metabolism, and apoptosis. Studies suggest its involvement in regulating mitochondrial morphology through interactions with fusion/fission machinery, though its precise molecular mechanisms remain unclear. Dysregulation of ARMC10 has been implicated in cancer progression, neurodegenerative disorders, and metabolic syndromes, highlighting its potential as a therapeutic target.

ARMC10 antibodies are essential tools for investigating its expression, localization, and function. These antibodies, typically developed in rabbit or mouse hosts, enable applications such as Western blotting, immunohistochemistry (IHC), immunofluorescence (IF), and co-immunoprecipitation (Co-IP). Validation data often include reactivity checks across species (human, mouse, rat) and knockdown/knockout controls to confirm specificity. Commercial ARMC10 antibodies are available from suppliers like Sigma-Aldrich, Abcam, and Invitrogen, but batch variability necessitates careful optimization. Recent research employs ARMC10 antibodies to explore its role in tumorigenesis, particularly in modulating mitochondrial apoptosis in cancers, and its interactions with pathways like AMPK/mTOR. Further studies are needed to unravel its multifaceted biological significance and clinical relevance.